Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014

E. Tsvetkova; S. Sud; N. Aucoin; J. Biagi; R. Burkes; B. Samson; S. Brule; C. Cripps; B. Colwell; C. Falkson; M. Dorreen; R. Goel; F. Halwani; J. Maroun; N. Michaud; M. Tehfe; M. Thirlwell; M. Vickers; T. Asmis

doi:10.3747/co.22.2603

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Article

1 August 2015

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014

and

The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

Hôpital de la Cité-de-la-Santé de Laval, Laval, QC, Canada

Queen’s University, Kingston, ON, Canada

⁴

Mount Sinai Hospital, Toronto, ON, Canada

Curr. Oncol.2015, 22(4), 305-315;https://doi.org/10.3747/co.22.2603

Version Notes

Order Reprints

Abstract

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Montreal, Quebec, 23–25 October 2014. Expert radiation, medical, and surgical oncologists and pathologists involved in the management of patients with gastrointestinal malignancies participated in presentations and discussions resulting in consensus statements on such hot topics as management of neuroendocrine tumours, advanced and metastatic pancreatic cancer, and metastatic colorectal cancer.

Keywords:

Neuroendocrine tumours; pancreatic cancer; colorectal cancer; screening; chemotherapy; radiation therapy; RAS testing

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Fertility Preservation in Reproductive-Age Women Facing Gonadotoxic Treatments

Unusual Presentation of Metastatic Sebaceous Crcinoma and Its Response to Chemotherapy: Is Genotyping a Right Answer for Guiding Chemotherapy in Rare Tumours?